SK4592001A3 - Atypical antipsychotic in combination with acetylcholinesterase inhibitor for improving cognition - Google Patents
Atypical antipsychotic in combination with acetylcholinesterase inhibitor for improving cognition Download PDFInfo
- Publication number
- SK4592001A3 SK4592001A3 SK459-2001A SK4592001A SK4592001A3 SK 4592001 A3 SK4592001 A3 SK 4592001A3 SK 4592001 A SK4592001 A SK 4592001A SK 4592001 A3 SK4592001 A3 SK 4592001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- atypical antipsychotic
- patients suffering
- antipsychotic agent
- active ingredient
- acetylcholinesterase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98203454 | 1998-10-16 | ||
PCT/EP1999/007804 WO2000023057A2 (fr) | 1998-10-16 | 1999-10-12 | Therapie visant a ameliorer la cognition |
Publications (1)
Publication Number | Publication Date |
---|---|
SK4592001A3 true SK4592001A3 (en) | 2001-12-03 |
Family
ID=8234219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK459-2001A SK4592001A3 (en) | 1998-10-16 | 1999-10-12 | Atypical antipsychotic in combination with acetylcholinesterase inhibitor for improving cognition |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1121131A2 (fr) |
JP (1) | JP2002527469A (fr) |
KR (1) | KR20010072878A (fr) |
CN (1) | CN1367697A (fr) |
AU (1) | AU6472799A (fr) |
BG (1) | BG105302A (fr) |
BR (1) | BR9914419A (fr) |
CA (1) | CA2345767A1 (fr) |
EE (1) | EE200100136A (fr) |
HK (1) | HK1039745A1 (fr) |
HR (1) | HRP20010262A2 (fr) |
HU (1) | HUP0103781A3 (fr) |
ID (1) | ID28441A (fr) |
IL (1) | IL142588A0 (fr) |
NO (1) | NO20011403D0 (fr) |
PL (1) | PL348107A1 (fr) |
SK (1) | SK4592001A3 (fr) |
TR (1) | TR200101082T2 (fr) |
WO (1) | WO2000023057A2 (fr) |
ZA (1) | ZA200103081B (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006201188B2 (en) * | 2001-02-05 | 2007-11-15 | Novartis Ag | New use of iloperidone |
GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
WO2003037337A1 (fr) | 2001-10-30 | 2003-05-08 | Novartis Ag | Preparations de depot d'iloperidone et de polymere en etoile |
GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
US20040192754A1 (en) * | 2003-03-24 | 2004-09-30 | Shapira Nathan Andrew | Methods for treating idiopathic hyperhidrosis and associated conditions |
TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
WO2006065233A1 (fr) * | 2004-12-10 | 2006-06-22 | Abbott Laboratories | Dérivés polycycliques de quinuclidine substitués par un bicyclohétérocycle condensé |
EP1776089A2 (fr) * | 2003-12-31 | 2007-04-25 | Actavis Group hf | Formulations de donepezil |
EP2089383B1 (fr) | 2006-11-09 | 2015-09-16 | Probiodrug AG | Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies |
ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
MX2009009234A (es) | 2007-03-01 | 2009-12-01 | Probiodrug Ag | Uso nuevo de inhibidores de ciclasa de glutaminilo. |
WO2008128985A1 (fr) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase |
MX2007008642A (es) * | 2007-07-16 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias. |
EA037187B1 (ru) | 2010-02-09 | 2021-02-17 | Дзе Джонс Хопкинс Юниверсити | Способ и композиция для лечения когнитивного расстройства |
US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CA2789440C (fr) | 2010-03-10 | 2020-03-24 | Probiodrug Ag | Inhibiteurs heterocycliques de la glutaminyl cyclase (qc, ec 2.3.2.5) |
JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
WO2014144801A1 (fr) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Procédés et compositions pour améliorer la fonction cognitive |
WO2014144663A1 (fr) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Procédés et compositions pour améliorer la fonction cognitive |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
CA2108880A1 (fr) * | 1991-05-14 | 1992-11-15 | Ernir Snorrason | Traitement du syndrome de fatigue avec des inhibiteurs de la cholinesterase |
WO1999007378A1 (fr) * | 1997-08-11 | 1999-02-18 | THE UNIVERSITY OF SOUTH FLORIDA A Corporation of the State of Florida | Antagonistes de la nicotine destines a des troubles neuropsychiatriques sensibles a la nicotine |
PT1073432E (pt) * | 1998-04-14 | 2007-10-22 | Gen Hospital Corp | Utilização da d-alanina ou da d-serina para o tratamento da esquizofrenia |
-
1999
- 1999-10-12 CA CA002345767A patent/CA2345767A1/fr not_active Abandoned
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Application Discontinuation
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 EP EP99952580A patent/EP1121131A2/fr not_active Withdrawn
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/fr not_active Application Discontinuation
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
-
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403D0/no not_active Application Discontinuation
- 2001-04-10 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown
-
2002
- 2002-01-10 HK HK02100158.6A patent/HK1039745A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1121131A2 (fr) | 2001-08-08 |
HUP0103781A3 (en) | 2003-09-29 |
WO2000023057A2 (fr) | 2000-04-27 |
CN1367697A (zh) | 2002-09-04 |
PL348107A1 (en) | 2002-05-06 |
NO20011403L (no) | 2001-03-20 |
KR20010072878A (ko) | 2001-07-31 |
HRP20010262A2 (en) | 2002-06-30 |
IL142588A0 (en) | 2002-03-10 |
AU6472799A (en) | 2000-05-08 |
EE200100136A (et) | 2002-06-17 |
WO2000023057A3 (fr) | 2000-07-27 |
JP2002527469A (ja) | 2002-08-27 |
CA2345767A1 (fr) | 2000-04-27 |
HUP0103781A2 (hu) | 2002-03-28 |
ID28441A (id) | 2001-05-24 |
NO20011403D0 (no) | 2001-03-20 |
TR200101082T2 (tr) | 2001-09-21 |
BG105302A (en) | 2001-11-30 |
HK1039745A1 (zh) | 2002-05-10 |
ZA200103081B (en) | 2002-07-12 |
BR9914419A (pt) | 2001-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK4592001A3 (en) | Atypical antipsychotic in combination with acetylcholinesterase inhibitor for improving cognition | |
US5945416A (en) | Method for treating pain | |
US8404703B2 (en) | Medicinal compositions containing aspirin | |
JP5084736B2 (ja) | 肺高血圧を処置するためのジアリールウレア | |
DE60009697T2 (de) | Verwendung von 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazin und dessen physiologisch akzeptablen salzen zur behandlung von bipolaren krankheiten und manie | |
US6319927B1 (en) | Method of using levocetirizine and pharmaceutical compositions containing the same for inducing sleep | |
SK104794A3 (en) | Drug useful in the treatment of motor neuron diseases | |
CA2449952A1 (fr) | Composition medicinale | |
EP2389937B1 (fr) | Compositions médicinales améliorant la fonction cérébrale | |
JP2001517202A (ja) | 痛み処置方法 | |
JP2005501108A (ja) | 神経変性治療におけるネフィラセタムの使用 | |
RU2023449C1 (ru) | Способ стабилизации 4-этил-2-гидроксиимино-5-нитро-3-гексенамида | |
US20080188523A1 (en) | Pharmaceutical composition comprising, in combination, saredutant and paroxetine | |
EP0783890A1 (fr) | Utilisation de la 2-méthyl-4-(4-méthyl-1-pipérazinyl)-10H-thiéno(2,3-b)(1,5)benzodiazépine pour le traitement de la dermatite fongique | |
CA1209047A (fr) | Compose therapeutique contenant un analogue du piracetam | |
SK50802006A3 (sk) | Kombinovaná farmaceutická kompozícia na inhibíciupoklesu kognitívnych funkcií | |
EP0671908B1 (fr) | Compositions pharmaceutiques comprenant des agonistes des recepteurs 5-ht 1? et des stimulateurs d'absorption | |
AU1083099A (en) | Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-(2-(4- fluorophenyl) ethyl)-4- piperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 | |
RU2001113270A (ru) | Лечение, направленное на улучшение познавательной способности | |
AU2004200993A1 (en) | Esters of (+)-alpha-(2,3-dimethoxyphenyl-[2-(4-flurophenyl) ethyl]-4-piperidinemethanol and their use as prodrugs of the 5HT2a receptor antagonist MDL 110,907 | |
KR20060130689A (ko) | 인지 기능의 감퇴를 억제하기 위한 혼합 약제 조성물 | |
JP2003183163A (ja) | 神経因性疼痛抑制剤 | |
RU97100648A (ru) | Бензопираны и их использование в качестве терапевтических агентов | |
BG65206B1 (bg) | Естери на (+)-алфа-(2,3-диметоксифенил)-1-[2-(4-флуорoфенил)етил]-4- пиперидинметанол, метод за тяхното получаване и приложението им като предшественици на 5ht2a рецепторния антагонист mdl 110,907 | |
HUT70439A (en) | Injectable solution for administration of one or more active compounds in situ and process for its preparation |